Clinical Trial to Evaluate Cardiovascular Outcomes in Patients

Recruiting

18 years - 99 years

All

10 participants needed

1 Location

Brief description of study

The purpose of this research study is to compare the performance of the investigational (experimental) tricuspid valve repair system plus optimal drug therapy with optimal drug therapy alone. Participants will be randomly assigned to treatment with either the TriClip device (device group) or No TriClip device (control group). Participants will be in this study until they have completed your 5-year follow-up visit.

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research, Cardiovascular, heart failure
Age: 18 years - 99 years
Gender: All

Age 18+ Doctor has determined a TriClip procedure is best option for patient

Updated on 04 Aug 2024. Study ID: 834258

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Clinical Trial to Evaluate Cardiovascular Outcomes in Patients Treated with the Tricuspid Valve Repair System (the “TriClip Device”)

Brief description of study

Detailed description of study

Eligibility of study

Find a site

Interested in the study